reiterateCPNGfinnhub
Citigroup Reiterates Buy Rating on Coupang, Inc. (CPNG)
Citigroup analysts reiterated a Buy rating on Coupang, Inc. (NYSE:CPNG) on February 10, 2026. Coupang, Inc.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Citigroup analysts reiterated a Buy rating on Coupang, Inc. (NYSE:CPNG) on February 10, 2026. Coupang, Inc.
Read moreMacquarie analysts reiterated a Neutral rating on Block, Inc. (OTC:BSQKZ) on February 11, 2026. Block, Inc.
Read moreBTIG analysts reiterated a Buy rating on Edwards Lifesciences Corporation (NYSE:EW) on February 11, 2026. Edwards Lifesciences Corporation operates in the Healthcare sector. The…
Read moreGoldman Sachs analysts reiterated a Buy rating on Edwards Lifesciences Corporation (NYSE:EW) on February 11, 2026. Edwards Lifesciences Corporation operates in the Healthcare…
Read morePiper Sandler analysts reiterated a Overweight rating on Edwards Lifesciences Corporation (NYSE:EW) on February 11, 2026. Edwards Lifesciences Corporation operates in the…
Read moreTruist Securities analysts reiterated a Hold rating on Edwards Lifesciences Corporation (NYSE:EW) on February 11, 2026. Edwards Lifesciences Corporation operates in the Healthcare…
Read moreWells Fargo analysts reiterated a Overweight rating on Edwards Lifesciences Corporation (NYSE:EW) on February 11, 2026. Edwards Lifesciences Corporation operates in the Healthcare…
Read morePiper Sandler analysts reiterated a Overweight rating on Motorola Solutions, Inc. (NYSE:MSI) on February 12, 2026. Motorola Solutions, Inc.
Read moreBarclays analysts reiterated a Overweight rating on Motorola Solutions, Inc. (NYSE:MSI) on February 12, 2026. Motorola Solutions, Inc.
Read moreJP Morgan analysts reiterated a Overweight rating on Motorola Solutions, Inc. (NYSE:MSI) on February 12, 2026. Motorola Solutions, Inc.
Read moreNeedham analysts reiterated a Buy rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on February 12, 2026. Alnylam Pharmaceuticals, Inc.
Read moreCitigroup analysts reiterated a Buy rating on Cloudflare, Inc. (NYSE:NET) on February 12, 2026. Cloudflare, Inc.
Read moreMizuho analysts reiterated a Outperform rating on Exelon Corporation (NASDAQ:EXC) on February 13, 2026. Exelon Corporation operates in the Utilities sector. The stock currently…
Read moreBMO Capital analysts reiterated a Outperform rating on Exelon Corporation (NASDAQ:EXC) on February 13, 2026. Exelon Corporation operates in the Utilities sector. The stock…
Read moreScotiabank analysts reiterated a Sector Perform rating on Exelon Corporation (NASDAQ:EXC) on February 13, 2026. Exelon Corporation operates in the Utilities sector. The stock…
Read moreWells Fargo analysts reiterated a Overweight rating on Exelon Corporation (NASDAQ:EXC) on February 13, 2026. Exelon Corporation operates in the Utilities sector. The stock…
Read moreUBS analysts upgraded Xcel Energy Inc. (NASDAQ:XEL) from Neutral to Buy on February 13, 2026. Xcel Energy Inc.
Read moreChardan Capital analysts reiterated a Buy rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on February 13, 2026. Alnylam Pharmaceuticals, Inc.
Read moreCitigroup analysts reiterated a Neutral rating on Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (NASDAQ:BRKRP) on February 13, 2026. Bruker Corporation…
Read moreGoldman Sachs analysts reiterated a Sell rating on Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (NASDAQ:BRKRP) on February 13, 2026. Bruker…
Read more